BioLine RX Ltd (BLRX) — Cash Flow Quality Index
BioLine RX Ltd (BLRX) has a Cash Flow Quality Index of -0.51x as of March 2025. Operating cash flow of ILA-2.59 Million is below net income of ILA5.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BLRX cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioLine RX Ltd Cash Flow Quality Index (2010–2010)
Historical Cash Flow Quality Index for BioLine RX Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BLRX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for BioLine RX Ltd (2010–2010)
Year-by-year earnings quality comparison for BioLine RX Ltd. For live market cap and the full company financial profile, see BLRX company net worth.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | 5.47x | ILA11.46 Million | ILA2.10 Million | — |